Activation of Endogenous Mesenchymal Stromal Cells as an Approach to Tissue Regeneration

Author:

Payushina O. V.1,Tsomartova D. A.1,Chereshneva Ye. V.1,Ivanova M. Yu.1,Lomanovskaya T. A.1,Pavlova M. S.1,Kuznetsov S. L.1

Affiliation:

1. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Abstract

Mesenchymal stromal cells (MSCs) which have a complex pro-regenerative effect on damaged tissues represent a promising resource for cell therapy for a wide range of diseases. However, transplantation of autologous or donor MSCs to a patient is associated with a number of problems, such as variability of cell properties depending on their source and cultivation conditions, a decrease in their therapeutic potential and the possibility of acquiring immunogenicity or tumorigenicity during in vitro expansion, and the invasiveness of the isolation procedure. One of the ways to avoid these problems can be the impact on endogenous MSCs by stimulating their directed migration into tissue defects, without the need for extraction from the body, in vitro cultivation and reintroduction to the patient. This review discusses approaches to activating the mobilization of MSCs from tissue niches and/or stimulating their migration to the target area, which can be considered as a safer, and possibly more effective alternative to MSC transplantation.

Publisher

The Russian Academy of Sciences

Reference106 articles.

1. Andrzejewska A., Lukomska B., Janowski M. 2019. Concise review: mesenchymal stem cells: from roots to boost. Stem Cells. V. 37. P. 855. https://doi.org/10.1002/stem.3016

2. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S. 2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. V. 362. P. 697. https://doi.org/10.1016/S0140-6736(03)14232-8

3. Balseanu A.T., Buga A.M., Catalin B., Wagner D.C., Boltze J., Zagrean A.M., Reymann K., Schaebitz W., Popa-Wagner A. 2014. Multimodal approaches for regenerative stroke therapies: combination of granulocyte colony-stimulating factor with bone marrow mesenchymal stem cells is not superior to G-CSF alone. Front. Aging Neurosci. V. 23. P. 130. https://doi.org/10.3389/fnagi.2014.00130

4. Bayo J., Real A., Fiore E.J., Malvicini M., Sganga L., Bolontrade M., Andriani O., Bizama C., Fresno C., Podhajcer O., Fernandez E., Gidekel M., Mazzolini G.D., García M.G. 2016. IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness. Oncotarget. V. 8. P. 80235. https://doi.org/10.18632/oncotarget.10288

5. Bradley M.J., Vicente D.A., Bograd B.A., Sanders E.M., Leonhardt C.L., Elster E.A., Davis T.A. 2017. Host responses to concurrent combined injuries in non-human primates. J. Inflamm. (Lond.). V. 14. P. 23. https://doi.org/10.1186/s12950-017-0170-7

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3